Skip to main content
. Author manuscript; available in PMC: 2018 Nov 30.
Published in final edited form as: Thromb Haemost. 2017 Nov 30;117(11):2063–2078. doi: 10.1160/TH17-01-0067

Figure 5. Extracellular CyPA enhances platelet-dependent thrombosis in vivo and in vitro.

Figure 5

Human blood was preincubated with 8H7-mAb or IgG control and stimulated with 200 nmol/L CyPA. Then the blood was perfused using a shear rate of 1000 seconds−1 (A) and 1700 seconds−1 (B) over a fibrillar type I collagen coated coverslip. (n ≤ 4) * means p ≤ 0.05 vs. untreated. (C) Murine blood was perfused over a CyPA/fibrillar type I collagen coated coverslip using a shear rate of 1700 seconds−1 after i.v. injection of 8H7-mAb or IgG control (n ≤ 8) * means p ≤ 0.05, scale bar 20 μm. 8H7-mAb reduceed thrombus formation in vitro, and as the next step the in vivo thrombus formation in mesenteric arterioles was analyzed in a FeCl3 model after administration of 8H7-mAb or IgG control (D/E). Representative pictures of the in vivo thrombus formation (E) and time to occlusion for individual mice (D). * means p ≤ 0.05, scale bar 50 μm.